Schroder Investment Management Group Aurinia Pharmaceuticals Inc. Transaction History
Schroder Investment Management Group
- $112 Billion
- Q2 2025
A detailed history of Schroder Investment Management Group transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 547,802 shares of AUPH stock, worth $6.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
547,802
Previous 314,785
74.02%
Holding current value
$6.64 Million
Previous $2.53 Million
83.36%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AUPH
# of Institutions
249Shares Held
62.6MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$122 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$112 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$48.1 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$33.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$29 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.72B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...